Table 1.
The number of seropositive and seronegative individuals, and the prevalence of anti-T.gondii antibodies in different age groups in dogs and cats and the proportion of seropositive cats and dogs representing various clinical disorders
| Age group (years) | Positive | Negative | Total | Seroprevalence (%) | a95% CI | |
|---|---|---|---|---|---|---|
| Cats (n = 193) | ||||||
| < 1 | 4 | 17 | 21 | 19.05 | 7.67-40.00 | |
| 1–3 | 24 | 24 | 48 | 50.00 | 36.39–63.61 | |
| 4–7 | 26 | 20 | 46 | 56.52 | 42.25–69.79 | |
| 8+ | 42 | 36 | 78 | 53.87 | 42.86–64.47 | |
| Dogs (n = 204) | ||||||
| < 1 | 0 | 22 | 22 | 0.00 | 0.00-14.87 | |
| 1–3 | 10 | 25 | 35 | 28.57 | 16.33–45.05 | |
| 4–7 | 13 | 31 | 44 | 29.55 | 18.16–44.22 | |
| 8+ | 36 | 67 | 103 | 34.95 | 26.44–44.55 | |
| Symptoms | (+) Total | % Positive | p-value | (+) Total | % Positive | p-value |
| Cats (n = 193) | Dogs (n = 204) | |||||
| Healthy | (22) 49 | 44.90 | 0.77 | (15) 55 | 27.27 | 0.44 |
| Gastrointestinal disorders | (9) 21 | 42.86 | (10) 35 | 28.57 | ||
| Respiratory disorders | (8) 14 | 57.14 | (4) 11 | 36.36 | ||
| Neurological disorders | (6) 12 | 50.00 | (5) 9 | 55.56 | ||
| Other | (51) 97 | 52.58 | (25) 94 | 26.60 | ||
a95% CI: lower and upper values for the 95% confidence interval.